[HTML][HTML] Exploring the role of Locus Coeruleus in Alzheimer's Disease: a Comprehensive Update on MRI studies and implications

A Galgani, FS Giorgi - Current Neurology and Neuroscience Reports, 2023 - Springer
Abstract Purpose of Review Performing a thorough review of magnetic resonance imaging
(MRI) studies assessing locus coeruleus (LC) integrity in ageing and Alzheimer's disease …

New approaches for the quantification and targeting of noradrenergic dysfunction in Alzheimer's disease

M David, PA Malhotra - Annals of Clinical and Translational …, 2022 - Wiley Online Library
There is clear, early noradrenergic dysfunction in Alzheimer's disease. This is likely
secondary to pathological tau deposition in the locus coeruleus, the pontine nucleus that …

[HTML][HTML] Correlation between cognition and plasma noradrenaline level in Alzheimer's disease: a potential new blood marker of disease evolution

LE Pillet, C Taccola, J Cotoni, H Thiriez, K André… - Translational …, 2020 - nature.com
Recent evidence showing degeneration of the noradrenergic system in the locus coeruleus
(LC) in Alzheimer's disease (AD) has motivated great interest in noradrenaline (NA) as a …

Investigation of the functional pathogenesis of mild cognitive impairment by localisation‐based locus coeruleus resting‐state fMRI

T Liebe, M Dordevic, J Kaufmann… - Human brain …, 2022 - Wiley Online Library
Dementia as one of the most prevalent diseases urges for a better understanding of the
central mechanisms responsible for clinical symptoms, and necessitates improvement of …

A case-control study of the locus coeruleus degeneration in Alzheimer's disease

R Hou, R Beardmore, C Holmes, C Osmond… - European …, 2021 - Elsevier
The locus coeruleus (LC) is the major source of noradrenaline, which plays a key role in
cognition. We aimed to detect the extent of the LC signal attenuation in Alzheimer's disease …

Brainstem volumetric integrity in preclinical and prodromal Alzheimer's disease

S Dutt, Y Li, M Mather, DA Nation… - Journal of …, 2020 - content.iospress.com
Background: Neuropathological studies have suggested the tau pathology observed in
Alzheimer's disease (AD) originates in brainstem nuclei, but no studies to date have …

Genetic ablation of Nrf2 exacerbates neurotoxic effects of acrylamide in mice

FA Ekuban, C Zong, M Takikawa, K Morikawa… - Toxicology, 2021 - Elsevier
Acrylamide (ACR), a recognized neurotoxicant in humans and experimental animals, is
widely used in industry and in food generated through Maillard reaction. Nuclear factor …

[HTML][HTML] New frontiers in Alzheimer's disease diagnostic: Monoamines and their derivatives in biological fluids

A Gallo, LE Pillet, R Verpillot - Experimental Gerontology, 2021 - Elsevier
Current diagnosis of Alzheimer's disease (AD) relies on a combination of
neuropsychological evaluations, biomarker measurements and brain imaging …

[HTML][HTML] Peripheral pathways to neurovascular unit dysfunction, cognitive impairment, and Alzheimer's Disease

AR Nelson - Frontiers in aging neuroscience, 2022 - frontiersin.org
Alzheimer's disease (AD) is the most common form of dementia. It was first described more
than a century ago, and scientists are acquiring new data and learning novel information …

Cognitive impairment in alzheimer's and metabolic diseases: a catecholaminergic hypothesis

K Guzmán-Ramos, D Osorio-Gómez… - Neuroscience, 2022 - Elsevier
Catecholaminergic transmission plays an essential role in both physiological and
pathological cognitive functions. Plastic changes subserving learning and memory …